Literature DB >> 31444603

ASO Author Reflections: Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ with Suspicion for Microinvasion on Core Needle Biopsy.

Meghan R Flanagan1, Hiram S Cody2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31444603      PMCID： PMC6906243          DOI： 10.1245/s10434-019-07747-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

Review 2.  Sentinel lymph node biopsy in patients with microinvasive breast cancer: a systematic review and meta-analysis.

Authors:  H Gojon; D Fawunmi; A Valachis
Journal:  Eur J Surg Oncol       Date:  2013-11-05       Impact factor: 4.424

3.  The utility of sentinel lymph node biopsy in patients with ductal carcinoma in situ suspicious for microinvasion on core biopsy.

Authors:  Jukes P Namm; Jeffrey Mueller; Masha Kocherginsky; Swati Kulkarni
Journal:  Ann Surg Oncol       Date:  2014-07-26       Impact factor: 5.344

4.  Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?

Authors:  Meghan R Flanagan; Michelle Stempel; Edi Brogi; Monica Morrow; Hiram S Cody
Journal:  Ann Surg Oncol       Date:  2019-05-30       Impact factor: 5.344

5.  The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database Analysis.

Authors:  Wenna Wang; Wenjie Zhu; Feng Du; Yang Luo; Binghe Xu
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379
  5 in total
  1 in total

1.  ASO Author Reflections: Clinical Benefit of Neoadjuvant Short-Course Radiotherapy for Upper-Third Rectal Tumors over Surgery Alone.

Authors:  Michael Flanagan; Cillian Clancy; John Burke
Journal:  Ann Surg Oncol       Date:  2021-03-29       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.